23rd Nov 2006 10:25
Biotrace International PLC23 November 2006 For Immediate Release 23 November 2006 BIOTRACE INTERNATIONAL PLC Holdings in Company Biotrace International Plc, a leading manufacturer of industrial microbiologyproducts was informed yesterday that as at close of business on 20 November2006, The Goldman Sachs Group Inc. ("GS Inc"), was interested, by attributiononly, in a total of 2,210,000 Ordinary 10p shares of the Group. The interest in2,210,000 ordinary shares arose from a beneficial interest held by Goldman SachsInternational, a wholly-owned indirect subsidiary of GS Inc. This notification relates to issued ordinary shares in the capital of the Groupand is given in fulfilment of the obligations imposed by sections 198-203 of theCompanies Act 1985. - ENDS - For further information, please contact: Biotrace International Plc Tel: 01656 641400Peter Morgan, Finance Director This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Bank Irel13.375